Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 386861 - 386880 out of 498375 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Saudi Arabia | (L01EG02) everolimus (adm: O) | AFINITOR 5 MG TABLET | 30 Blister, 5 mg, Oral use, Tablet, 5mg , Blister, Tablet | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell; Breast Neoplasms; Pancreatic Neoplasms | NOVARTIS / NOVARTISPharmaSteinAG |
| Saudi Arabia | (L01EX03) pazopanib (adm: O) | PORENZA | 30 Bottle, 200 mg, Oral use, Film-coated tablet, 200mg , Bottle, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | MSPharmaSaudi(MSPS) / PharmacarePremiumLtd |
| Saudi Arabia | (L01EX03) pazopanib (adm: O) | PORENZA | 30 Bottle, 400 mg, Oral use, Film-coated tablet, 400mg , Bottle, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | MSPharmaSaudi(MSPS) / PharmacarePremiumLtd |
| Saudi Arabia | (L01FD01) trastuzumab | HERCEPTIN 120 mg/ml Solution For Injection | 1 Vial, 5ml, 120 mg/ml, Subcutaneous use, Solution for injection, 120mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | ROCHE / F.Hoffmann-LaRocheLtd. |
| Saudi Arabia | (L01FD03) trastuzumab emtansine | KADCYLA 100 mg powder for concentrate for solution for infusion | 1 Vial, 100 mg, Intravenous use, Powder for concentrate for solution for infusion, 100mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ROCHE / PatheonManufacturingServicesLLC |
| Saudi Arabia | (L01FD03) trastuzumab emtansine | KADCYLA 160 mg powder for concentrate for solution for infusion | 1 Vial, 160 mg, Intravenous use, Powder for concentrate for solution for infusion, 160mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ROCHE / PatheonManufacturingServicesLLC |
| Saudi Arabia | (L01FF07) dostarlimab | Jemperli | 1 Vial, 10ml, 50 mg/ml, Intravenous use, Concentrate for solution for infusion, 50mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Endometrial Neoplasms | GLAXOSAUDIARABIA / AJINOMOTOALTHEAINCORPORATED |
| Saudi Arabia | (L01FG01) bevacizumab | KRABEVA 100 per 4 ml | 1 Vial, 4ml, 25 mg/ml, Intravenous use, Concentrate for solution for infusion, 25mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | BioconBiologicsLimited / BioconLimited |
| Saudi Arabia | (L01FG01) bevacizumab | KRABEVA 400 mg per 16 ml | 1 Vial, 16ml, 25 mg/ml, Intravenous use, Concentrate for solution for infusion, 25mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | BioconBiologicsLimited / BioconLimited |
| Saudi Arabia | (L01XC15) obinutuzumab | GAZYVA 25 mg/ml concentrate for solution for infusion | 1 Vial, 40ml, 25 mg/ml, Intravenous use, Concentrate for solution for infusion, 25mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
n/a | ROCHE / ROCHEDIAGNOSTICS |
| Saudi Arabia | (L01XE33) palbociclib | Cryptario | 21 Blister, 100 mg, Oral use, Film-coated tablet, 100mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | SAJA-SAUDIARABIANJAPANESEPHARMACEUTICALCO / SynthonHispaniaSL |
| Saudi Arabia | (L01XE33) palbociclib | Cryptario | 21 Blister, 75 mg, Oral use, Film-coated tablet, 75mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | SAJA-SAUDIARABIANJAPANESEPHARMACEUTICALCO / SynthonHispaniaSL |
| Saudi Arabia | (L01XE33) palbociclib | Cryptario | 21 Blister, 125 mg, Oral use, Film-coated tablet, 125mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | SAJA-SAUDIARABIANJAPANESEPHARMACEUTICALCO / SynthonHispaniaSL |
| Saudi Arabia | (L01XE33) palbociclib | Pabrolib | 21 Bottle, 100 mg, Oral use, Capsule, hard, 100mg , Bottle, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
n/a | TabukPharmaceuticalManufacturingCompany / AizantDrugResearchSolutionsPvt.Ltd |
| Saudi Arabia | (L01XE33) palbociclib | Pabrolib | 21 Bottle, 75 mg, Oral use, Capsule, hard, 75mg , Bottle, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
n/a | TabukPharmaceuticalManufacturingCompany / AizantDrugResearchSolutionsPvt.Ltd |
| Saudi Arabia | (L01XE51) acalabrutinib | Calquence | 60 Blister, 100 mg, Oral use, Film-coated tablet, 100mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell | AstraZenecaUKLimited / AstraZenecaAB |
| Saudi Arabia | (L01XK52) niraparib and abiraterone | Akeega | 56 Blister, 50,500 mg, Oral use, Film-coated tablet, 50,500mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms, Castration-Resistant | Janssen-CilagInternationalNV / PATHEON |
| Saudi Arabia | (L01XK52) niraparib and abiraterone | Akeega | 56 Blister, 100,500 mg, Oral use, Film-coated tablet, 100,500mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms, Castration-Resistant | Janssen-CilagInternationalNV / PATHEON |
| Saudi Arabia | (L02AE02) leuprorelin (adm: P, depot inj) | ELIGARD 22.5 MG POWDER FOR SOLUTION FOR INJECTION | 1 Vial, 22.5 mg, Subcutaneous use, Powder and solvent for solution for injection, 22.5mg , Vial, Powder and solvent for solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | ASTELLASPHARMA / TOLMARINC. |
| Saudi Arabia | (L02AE02) leuprorelin (adm: P, depot inj) | ELIGARD 45 MG POWDER FOR SOLUTION FOR INJECTION | 1 Vial, 45 mg, Subcutaneous use, Powder and solvent for solution for injection, 45mg , Vial, Powder and solvent for solution for injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | ASTELLASPHARMA / TOLMARINC. |
Pages
